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Abstract
Introduction
The number of adolescents with a severe chronic disease has increased in high-income countries
due to improvements in the prognosis of childhood-onset chronic conditions. The transition from
childhood to adulthood is a critical period that may be associated with increased mortality and
morbidity. We aimed to estimate the prevalence of adolescents with a long-term disease (LTD) in
France and assess their mortality and hospitalization risks relative to the general population.
Materials and methods
We extracted a population-based cohort from the French national health insurance data-
base that included 61,119 subjects who reached 14 years of age between 2005 and 2014.
LTDs are diagnosed by patients’ physicians and then confirmed and registered by a physi-
cian of the national health insurance system. We assessed mortality and hospitalizations
using data of patients who were between 14 and 21 years-old.
Results
Among 14-year-old adolescents, 3.30% (95% confidence interval: 3.16–3.44) had a LTD.
Their mortality rate between the ages of 14 and 21 years was 20.9/10,000 person-years
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(13.7–32.1) versus 1.9 (1.5–2.5) for adolescents without a LTD. Mortality was higher in
males than females in youths without a LTD, but not in those with a LTD. We found a similar
pattern for the risk of hospitalization for an external cause. The five-year probability of hospi-
talization was 61.8% among youths with a LTD versus 42.7% for those without. The rate of
planned hospitalizations sharply fell at 19 years-of-age among youths with a LTD, whereas
the rate of unplanned hospitalizations remained stable.
Conclusion
The 3% of youths with a LTD have ten-fold higher mortality than those without and a high
risk of hospitalization. The decrease in the rate of planned hospitalizations at age 19 among
youths with a LTD may indicate differences in medical practice after transfer to adult care or
a break in medical care.
Introduction
The prognosis of childhood-onset chronic conditions has improved in recent decades in high-
income countries, such that more patients now reach adulthood. For example, the proportion
of cystic fibrosis patients reaching adulthood (>18 years of age) increased from 27% to 56%
between 1982 and 2007 and is forecasted to reach approximately 75% by 2025 in Western
European countries [1,2]. It is estimated that almost 90% of children with congenital heart dis-
eases will survive into adulthood, together with 94% of children with sickle cell anemia [3,4].
The population of perinatally HIV-infected patients is also ageing [5]. Better survival has likely
led to an increase in the number of adolescents living with a chronic disease, but little
national-level data are available on this subject.
Youths living with a chronic disease since childhood share many concerns during transition
to adulthood [6], including taking increasing responsibility for their health and healthcare [7–
10]. It is important to study this period of life, because adolescence is a critical period that may
be associated with poor outcomes [6]. Epidemiological data on mortality and healthcare use in
adolescents and young adults are yet sparse and often limited to a specific disease. Some stud-
ies have reported higher rates of healthcare use, either planned, unplanned, or both after entry
into adolescence or young adulthood for patients with a childhood-onset chronic disease [11–
17]. Conducting non-disease-specific studies could provide researchers and decision makers
with original insights on how transition to adulthood is related to prognosis and planned or
unplanned healthcare use. Such information could lead to a better understanding of the epide-
miology of these diseases in adolescents and young adults and improvements in healthcare
organization.
Furthermore, these youths must face the challenges of this period related to physiological,
psychological, and socio-economic changes, as all adolescents. Conducting studies comparing
youths with or without a chronic disease could help identify the role of the chronic condition
in healthcare use versus that of entry into adulthood.
The French national health insurance database is one of the largest databases in the world
and has been extensively used to guide public health policies in France, as these data allow sys-
tematic follow-up of all medical care received in France, including that of the low-income pop-
ulation [18–20]. With the Universal Health Coverage Act (opening up the right to statutory
health insurance coverage on the basis of residence in France), data on almost all French
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residents, i.e., people living in France (with or without French nationality), are registered in
this database. In addition, a list of major groups of chronic diseases, for which the severity
and/or chronic nature requires prolonged treatment and costly therapy, has been established
by decree as “Affections de Longue Durée” (long-term diseases, LTD) to allow patients to
receive full reimbursement for expenditures related to the LTD. This provided the opportunity
to estimate the prevalence of adolescents with a LTD diagnosed before 14 years of age at the
national level and to describe the mortality and short-stay hospitalization rates between youths
from 14 to 21 years of age, with or without a LTD.
Materials and methods
The EGB
The French national health insurance offers access to a large ongoing random sampling of
801,047 (at the time of this study) for research purposes, the Echantillon Généraliste des Bénéfi-
ciaires (EGB)[General Beneficiaries Sample] [18,21,22]. The EGB includes exhaustive records
of hospitalizations in short-stay units (medical, surgical, obstetrical) from the national hospital
discharge database, from 2005 to the end of 2015, and all data on LTD and mortality for sub-
jects insured under the French general health insurance schemes, representing 80% of the pop-
ulation. The other types of hospitalizations (i.e., hospitalizations in psychiatric units, home-
hospitalizations, and hospitalization in long-stay units) were not exhaustively recorded in the
database during the study period and were thus not analyzed.
Inclusion criteria
We selected all 61,119 adolescents from the EGB insured under the general scheme, who had
reached the age of 14 years during the period from 01/03/2005 to 31/12/2014. We did not con-
sider those who reached 14 after 2014 to allow at least 1 year of observation. This represents a
sample of the generation born between 01/03/1991 and 31/12/1999 who were still alive and liv-
ing in France at the age of 14.
Study design
We selected a retrospective cohort using data of youths between the ages of 14 and 21 years to
compare mortality and hospitalization rates between adolescents with or without a LTD. This
age range, from one year before healthcare adulthood (in France, patients can be managed in
adult care from the age of 15 years) to three years after legal adulthood (18 years old), thus cov-
ered the period of transition to young adulthood.
Definition and classification of long-term diseases
LTD registration is obtained at the request of a patient’s physician and must be validated by
the health insurance system physician, who codes the diagnosis using the International Classi-
fication of Diseases version 10 (ICD-10). Thirty-eight diseases registered before the age of 14
in our study population were identified as long-term, based on the LTD diagnosis codes.
Trauma and burns were not considered as LTDs, nor tuberculosis, because such a condition
should be resolved with antibiotic treatment and not last until adulthood. LTDs were classified
into three categories defined in a previous Canadian study exploring youths with chronic
health conditions [15]: chronic mental-health conditions, non-complex chronic conditions
(chronic conditions typically affecting a single organ system), and complex chronic conditions
(chronic medical conditions in which multiple morbidities and/or multi-organ manifestations
are common) (S1 Table).
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Overall, 2,019 subjects had at least one LTD registration before the age of 14 years, and
were thus included in the LTD group for this study. The comparison group (N = 59,100) com-
prised the subjects without a LTD registration before the age of 14 years. Among them, the fol-
low-up of those registered for a LTD after 14 (N = 879) was censored at LTD registration.
Outcomes
We studied two types of outcomes: 1) all-cause mortality, using data from the national death
registry and 2) hospitalizations in short-stay units. Two categories of hospitalizations were
considered: unplanned, defined as an admission through an emergency department (ED) and
planned, without admission through an ED. We also explored hospitalizations for an external
cause, as a proxy of exposure to high-risk situations, such as injuries and road accidents, which
are major causes of death in youths. An external cause was defined as a main diagnosis from
the ICD-10 chapter “Injury, poisoning, and certain other consequences of external causes”,
excluding complications of medical or surgical care, allergies, or intoxication by non-psycho-
tropic drugs, which may be related to the LTD.
Statistical methods
We first estimated the overall and gender-specific prevalence of the subjects with a LTD
among adolescents aged 14 years. Then, overall and gender-specific annual mortality rates
between the ages of 14 and 21 years were estimated by LTD status. Mortality rates were com-
pared between females and males by estimating rate ratios with a 95% confidence interval
(95%CI). The interaction between gender and LTD status towards mortality was tested using a
Cox model. We then estimated the probability of being hospitalized by the age of 21 years,
using the Kaplan-Meier method, by setting the time scale to age, and performed log-rank tests
to compare survival curves. The repartition of the main diagnosis (ICD-10 chapter) of each
stay was described by LTD status and gender for planned and unplanned hospitalizations. The
evolution of the annual incidence rates of hospitalization by age were described from 14 to 21
years of age. The analyses were performed using SAS Enterprise Guide 4.3 software, SAS Insti-
tute Inc., Cary, NC and STATA 13.1 (StataCorp LP Lakeway Drive College Station, Texas
77845 USA).
Ethical approval
A specific ethics committee approval was not required for this study. INSERM, as a health
research institute, has been authorized to use the EGB database by the French data protection
authority (Commission Nationale de l’Informatique et des Liberte´s, CNIL), provided that the
researcher follows specific training with certification, as the first author (Antoine Rachas) has
obtained. Then he has been authorized to access and analyze the EGB database for this study.
Results
Prevalence of long-term diseases at the age of 14 years
Among the 801,047 subjects included in the EGB, 61,119 were eligible and included in this
analysis (S1 Fig). Among them, 3.30% (95%CI: 3.16–3.44; N = 2,019) had a LTD at the age of
14 years (Table 1) and 879 were registered for a LTD after the age of 14 years and were cen-
sored at date of LTD registration. LTDs were significantly less frequent among females
(2.78%) than males (3.80%). A chronic mental health disease was present in 0.81% of subjects
(0.43% of females, 1.18% of males), a non-complex chronic condition in 1.10% (0.93% of
females, 1.26% of males), and a complex chronic condition in 1.39% (1.42% of females, 1.36%
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Table 1. Prevalence of subjects with a long-term disease at 14 years of age.
Category Group Conditions All (N = 61,119) Females (N = 29,860) Males (N = 31,259)
n Pr, % (95%CI) n Pr, % (95%CI) n Pr, % (95%CI)
All All All 2,019 3.30 (3.16;3.44) 831 2.78 (2.59;2.97) 1,188 3.80 (3.59;4.01)
Mental All All 498 0.81 (0.74;0.88) 129 0.43 (0.36;0.50) 369 1.18 (1.06;1.30)
Psychiatric diseases Autism spectrum disorders 166 0.27 (0.23;0.31) 39 0.13 (0.09;0.17) 127 0.41 (0.34;0.48)
Specific personality disorders 120 0.20 (0.16;0.24) 28 0.09 (0.06;0.12) 92 0.29 (0.23;0.35)
Psychotic disorders 22 0.04 (0.02;0.06) 10 0.03 (0.01;0.05) 12 0.04 (0.02;0.06)
Neurotic, emotional, mood disorders 135 0.22 (0.18;0.26) 37 0.12 (0.08;0.16) 98 0.31 (0.25;0.37)
Other psychological development disorder 54 0.09 (0.07;0.11) 14 0.05 (0.02;0.08) 40 0.13 (0.09;0.17)
Other psychiatric affections 1 0.00 (0.00;0.00) 1 0.00 (0.00;0.00) 0 0.00 (0.00;0.00)
Non-
complex
All All 671 1.10 (1.02;1.18) 278 0.93 (0.82;1.04) 393 1.26 (1.14;1.38)
Endocrine and metabolic
diseases
Type 1 and type 2 diabetes 114 0.19 (0.16;0.22) 48 0.16 (0.11;0.21) 66 0.21 (0.16;0.26)
Respiratory diseases Persistent asthma 235 0.38 (0.33;0.43) 88 0.29 (0.23;0.35) 147 0.47 (0.39;0.55)
Other serious chronic respiratory insufficiency 17 0.03 (0.02;0.04) 8 0.03 (0.01;0.05) 9 0.03 (0.01;0.05)
Vascular diseases Chronic arteriopathies with ischemic manifestations 3 0.00 (0.00;0.00) 3 0.01 (0.00;0.02) 0 0.00 (0.00;0.00)
Severe hypertension 3 0.00 (0.00;0.00) 1 0.00 (0.00;0.00) 2 0.01 (0.00;0.02)
Heart disease Severe congenital heart disease 110 0.18 (0.15;0.21) 48 0.16 (0.11;0.21) 62 0.20 (0.15;0.25)
Other heart diseases 23 0.04 (0.02;0.06) 12 0.04 (0.02;0.06) 11 0.04 (0.02;0.06)
Kidney diseases Severe chronic kidney disease and primitive nephrotic
syndrome
47 0.08 (0.06;0.10) 24 0.08 (0.05;0.11) 23 0.07 (0.04;0.10)
Liver diseases Active chronic liver disease and cirrhosis 15 0.02 (0.01;0.03) 8 0.03 (0.01;0.05) 7 0.02 (0.00;0.04)
Inflammatory Bowel Disease Progressive Crohn’s disease and ulcerative colitis 26 0.04 (0.02;0.06) 13 0.04 (0.02;0.06) 13 0.04 (0.02;0.06)
Malignancies Malignant tumor, malignant disease of lymphatic tissue
or blood
78 0.13 (0.10;0.16) 25 0.08 (0.05;0.11) 53 0.17 (0.12;0.22)
Complex All All 850 1.39 (1.30;1.48) 424 1.42 (1.29;1.55) 426 1.36 (1.23;1.49)
Chromosome abnormalities Down syndrome 45 0.07 (0.05;0.09) 19 0.06 (0.03;0.09) 26 0.08 (0.05;0.11)
Other chromosome abnormalities 15 0.02 (0.01;0.03) 10 0.03 (0.01;0.05) 5 0.02 (0.00;0.04)
Neurological and muscular
diseases
Cerebral palsy 89 0.15 (0.12;0.18) 37 0.12 (0.08;0.16) 52 0.17 (0.12;0.22)
Paraplegia 11 0.02 (0.01;0.03) 6 0.02 (0.00;0.04) 5 0.02 (0.00;0.04)
Severe epilepsy 94 0.15 (0.12;0.18) 45 0.15 (0.11;0.19) 49 0.16 (0.12;0.20)
Other serious neurological and muscular diseases 72 0.12 (0.09;0.15) 30 0.10 (0.06;0.14) 42 0.13 (0.09;0.17)
Mental retardation Mental retardation 152 0.25 (0.21;0.29) 48 0.16 (0.11;0.21) 104 0.33 (0.27;0.39)
Immunodeficiencies Severe primary immunodeficiency requiring prolonged
treatment
9 0.01 (0.00;0.02) 1 0.00 (0.00;0.00) 8 0.03 (0.01;0.05)
HIV infection 15 0.02 (0.01;0.03) 6 0.02 (0.00;0.04) 9 0.03 (0.01;0.05)
Medullary deficiencies and other chronic cytopenias 3 0.00 (0.00;0.00) 1 0.00 (0.00;0.00) 2 0.01 (0.00;0.02)
Hemolysis Hemoglobinopathies 17 0.03 (0.02;0.04) 6 0.02 (0.00;0.04) 11 0.04 (0.02;0.06)
Other constitutional chronic hemolysis, acquired
hemolysis
5 0.01 (0.00;0.02) 3 0.01 (0.00;0.02) 2 0.01 (0.00;0.02)
Rheumatologic and systemic
diseases
Progressive rheumatoid arthritis 5 0.01 (0.00;0.02) 2 0.01 (0.00;0.02) 3 0.01 (0.00;0.02)
Juvenile arthritis 16 0.03 (0.02;0.04) 8 0.03 (0.01;0.05) 8 0.03 (0.01;0.05)
Progressive structural scoliosis 139 0.23 (0.19;0.27) 124 0.42 (0.35;0.49) 15 0.05 (0.03;0.07)
Vasculitis, systemic lupus erythematosus, systemic
scleroderma
3 0.00 (0.00;0.00) 2 0.01 (0.00;0.02) 1 0.00 (0.00;0.00)
Hemorrhagic diseases Hemophilia and serious constitutional disorders of
hemostasis
13 0.02 (0.01;0.03) 3 0.01 (0.00;0.02) 10 0.03 (0.01;0.05)
Purpura and other hemorrhagic conditions 11 0.02 (0.01;0.03) 3 0.01 (0.00;0.02) 8 0.03 (0.01;0.05)
Endocrine and metabolic
diseases
Inherited metabolic diseases requiring prolonged
treatment
83 0.14 (0.11;0.17) 46 0.15 (0.11;0.19) 37 0.12 (0.08;0.16)
Respiratory diseases Cystic fibrosis 5 0.01 (0.00;0.02) 2 0.01 (0.00;0.02) 3 0.01 (0.00;0.02)
Vascular diseases Disabling stroke 21 0.03 (0.02;0.04) 11 0.04 (0.02;0.06) 10 0.03 (0.01;0.05)
Multiple diseases Multiple diseases 27 0.04 (0.02;0.06) 11 0.04 (0.02;0.06) 16 0.05 (0.03;0.07)
Abbreviations: 95%CI, 95% confidence interval; Pr, prevalence
https://doi.org/10.1371/journal.pone.0193729.t001
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of males). The five most frequent diseases were persistent asthma (0.38%), autism spectrum
disorders (0.27%), mental retardation (0.25%), progressive structural scoliosis (0.23%), and
neurotic, emotional, and mood disorders (0.22%).
Mortality
Twenty-one subjects with a LTD and 56 with no LTD died between the ages of 14 and 21 years
(Table 2). The mortality rates per 10,000 person-years were 20.9 [95%CI: 13.7–32.1] and 1.9
[1.5–2.5], respectively. Mortality rate was the highest in the subjects with a complex chronic
condition (30.9/10,000 person-years [17.9–53.2]). Among those with no LTD, females were
less likely to die than males, with a mortality rate ratio (MRR) of 0.2; 95%CI: 0.1–0.4. This was
not the case for those with a LTD (MRR: 1.3; 95%CI: 0.5–3.4). The test for interaction between
gender and LTD status was significant (p = 0.001).
Overall hospitalizations
The probability of being hospitalized at least once between the ages of 14 and 21 years, esti-
mated using the Kaplan-Meier method, was 61.8% for subjects with a LTD and 42.7% for
those without (Table 3); log-rank p-value< 0.0001. The probability was the highest for sub-
jects with a complex chronic condition (67.2%). Females were more likely to be hospitalized
than males (Fig 1A), in both the LTD (67.5% vs. 57.5%, log-rank p-value < 0.001) and no LTD
groups (46.6% vs. 38.9%, log-rank p-value < 0.0001).
Planned and unplanned hospitalizations
The probability of planned hospitalization by the age of 21 years was also higher for subjects
with a LTD than for those without. It was also higher in females than males in both the LTD
(59.9% vs. 49.6%, log-rank p-value = 0.001) and no LTD groups (39.9% vs. 30.7%, log-rank p-
value <0.0001) (Fig 1B). The probability of unplanned hospitalization of subjects with a LTD
was non-significantly higher for females than males (23.9% vs. 20.4%, log-rank p-
value = 0.060), whereas it was almost identical between females and males without a LTD
(13.7% vs. 13.6% respectively; log-rank p-value = 0.84) (Fig 1C).
The most frequent primary ICD-10 diagnosis for unplanned hospitalizations was “Injury,
poisoning, and certain other consequences of external causes” for both males and females with
no LTD (20.3% of stays for females, 41.6% for males) and for males with a LTD (17.5%) (S3
Table). The most frequent diagnosis for females with a LTD was “Symptoms, signs, and
Table 2. Overall and gender-specific mortality between 14 and 21 years of age according to long-term disease.
All (N = 61,119) Females (N = 29,860) Males (N = 31,259) MRR (95%CI),
females vs. malesn MR (95%CI), per
10,000 PY
n MR (95%CI), per
10,000 PY
n MR (95%CI), per
10,000 PY
All 77 2.6 (2.1–3.2) 19 1.3 (0.8–2.0) 58 3.8 (2.9–4.9) 0.3 (0.2–0.6)
No LTD 56 1.9 (1.5–2.5) 9 0.6 (0.3–1.2) 47 3.2 (2.4–4.2) 0.2 (0.1–0.4)
LTD 21 20.9 (13.7–32.1) 10 23.9 (12.8–44.3) 11 18.4 (10.2–33.2) 1.3 (0.5–3.4)
Mental 2 8.2 (2.1–32.9) 1 15.0 (2.1–106.6) 1 5.4 (0.8–38.6) 2.8 (0.0–217.1)
Non-
complex
6 17.7 (8.0–39.5) 4 29.0 (10.9–77.4) 2 10.0 (2.5–40.1) 2.9 (0.4–32.0)
Complex 13 30.9 (17.9–53.2) 5 23.3 (9.7–55.9) 8 37.1 (18.6–74.3) 0.6 (0.2–2.2)
Abbreviations: LTD, long-term disease; MR, mortality rate; MRR, mortality rate ratio; PY, person-year; 95%CI, 95%
confidence interval
https://doi.org/10.1371/journal.pone.0193729.t002
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abnormal clinical and laboratory findings, not elsewhere classified” (16.4%). “Pregnancy,
childbirth and the puerperium” represented 14.9% of the stays for females without a LTD and
4.5% for those with a LTD.
Evolution of hospitalization rates by age
The hospitalization rate for subjects with a LTD remained stable from 14 (24.6 per 100 person-
years; 95%CI: 22.2–26.9) to 18 years of age (23.1; 20.2–26.1) and fell sharply at the age of 19
years (17.0; 14.2–19.7) to 14.1 (10.9–17.3) by the age of 21 (Fig 2). This decrease did not occur
for subjects with no LTD, for which the rate of hospitalizations was 7.5 (95%CI: 7.2–7.7) at 14,
9.2 (8.9–9.5) at 18, and 9.3 (8.9–9.8) at 21 years of age, per 100 person-years. The overall
decrease was the highest for youths with a complex chronic condition (S2 Fig). The fall in the
rate at 19 years of age concerned planned, but not unplanned, hospitalizations, which
remained stable between the ages of 14 and 21 years.
Hospitalization for an external cause
Males in the group with no LTD were approximately 3.5-times more likely than females to be
hospitalized for an external cause (10.0% vs. 2.8%; log-rank p-value< 0.0001), whereas the
Table 3. Overall and gender-specific probabilities of short-stay hospitalizations between the ages of 14 and 21 years according to the presence of a long-term
disease.
Outcome Group All (N = 61,119) Females (N = 29,860) Males (N = 31,259)
n Prob. (95%CI), % n Prob. (95%CI), % n Prob. (95%CI), %
 1 Hospitalization No LTD 19,629 42.7 (42.2–43.2) 10,426 46.6 (45.9–47.3) 9,203 38.9 (38.3–39.6)
LTD 1,025 61.8 (59.1–64.5) 465 67.5 (63.5–71.4) 560 57.5 (53.9–61.0)
Mental 192 50.7 (45.1–56.5) 65 65.6 (55.2–75.8) 127 44.8 (38.4–51.7)
Non-complex 355 62.9 (58.4–67.3) 159 68.5 (61.6–75.1) 196 58.6 (52.9–64.5)
Complex 478 67.2 (63.2–71.2) 241 67.4 (61.9–72.8) 237 67.0 (61.2–72.8)
 1 Planned hospitalization No LTD 16,176 35.2 (34.7–35.7) 8,883 39.9 (39.2–40.6) 7,293 30.7 (30.0–31.3)
LTD 902 54.0 (51.3–56.7) 412 59.9 (55.9–64.0) 490 49.6 (46.1–53.1)
Mental 155 40.9 (35.5–46.7) 53 54.4 (43.8–65.8) 102 35.8 (29.9–42.5)
Non-complex 314 55.0 (50.6–59.6) 140 60.1 (53.2–67.2) 174 51.4 (45.7–57.3)
Complex 433 60.7 (56.6–64.7) 219 61.4 (55.9–67.1) 214 59.7 (53.9–65.6)
 1 Unplanned hospitalization No LTD 6,338 13.7 (13.4–14.0) 3,123 13.7 (13.3–14.2) 3,215 13.6 (13.2–14.1)
LTD 367 21.8 (19.8–24.0) 168 23.9 (20.8–27.5) 199 20.4 (17.8–23.2)
Mental 66 17.5 (13.9–22.1) 26 27.0 (18.8–37.7) 40 14.0 (10.3–19.0)
Non-complex 138 24.1 (20.7–28.0) 66 28.1 (22.5–34.7) 72 21.2 (17.1–26.1)
Complex 163 22.6 (19.5–26.0) 76 20.4 (16.5–25.0) 87 24.9 (20.4–30.2)
 1 Hospitalization for an external cause No LTD 3,016 6.4 (6.2–6.7) 663 2.8 (2.6–3.0) 2,353 10.0 (9.6–10.4)
LTD 98 6.0 (4.9–7.3) 25 3.5 (2.4–5.2) 73 7.8 (6.2–9.8)
Mental 25 6.7 (4.5–9.9) 5 4.4 (1.8–10.5) 20 7.5 (4.8–11.6)
Non-complex 38 7.0 (5.1–9.6) 9 4.2 (2.1–8.1) 29 9.0 (6.3–12.9)
Complex 35 4.9 (3.5–6.8) 11 2.8 (1.5–5.0) 24 7.0 (4.7–10.5)
n represents the number of events. Probabilities were estimated by the Kaplan-Meier method. The total number of subjects with 1 hospitalization is not the sum of
numbers with planned and unplanned hospitalizations, because a subject could have both types of hospitalizations during the study period.
different from a complication of medical or surgical care, allergy, or intoxication by non-psychotropic drugs.
Abbreviations: LTD, long-term disease; 95%CI, 95% confidence interval.
https://doi.org/10.1371/journal.pone.0193729.t003
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gender difference was smaller in the LTD group (7.8% vs. 3.5%; log-rank p-value < 0.001); p
for interaction = 0.033 (Table 3, Fig 1D).
Discussion
This study is the first to provide national estimates for the prevalence of adolescents with a
LTD diagnosed before 14 years of age and their mortality and hospitalization rates based on
medical data for adolescents living in France.
During the 2005–2014 period, 3.30% (95%CI: 3.16–3.44) of adolescents insured under the
French general health insurance scheme had a LTD at 14 years of age. No other national stud-
ies have been published concerning the overall prevalence of youths with chronic diseases,
except the 2011/2012 household National Survey of Children’s Health [23], which used a very
different approach. It was based on parent-reported data and a broad definition of chronic
conditions, including, for example, any kind of hearing or speech problems. In our study, the
diagnoses of LTDs were double-validated by medical practitioners (the patient’s physician and
the health insurance system physician). Based on this medical approach of reporting LTDs, we
could focus specifically on chronic diseases that require costly and long-term care, are poten-
tially life-threatening, or lead to handicaps or medical complications.
A strength of this study was the use of a large representative sample of the population
insured under the general scheme of the French national health insurance [18], with no selec-
tion bias, as the EGB is a random sample with an anonymous procedure that does not require
patient agreement. Nevertheless, the prevalence of LTDs may have been slightly underesti-
mated for two reasons. First, some patients have not yet been diagnosed. Second, some patients
are eligible for access to free care without requesting LTD registration, but this is unlikely to
concern patients with the most severe conditions, who have greater healthcare needs.
A notable strength of our study was the accuracy of mortality estimates, as deaths are
exhaustively registered in the French death register. The overall and gender-specific mortality
rates were very close to those reported in the French national data.[24]. The mortality rates
between the ages of 14 and 21 years for subjects with and without a LTD were 20.9/10,000
Fig 1. Probability of hospitalizations in short-stay units by gender and long-term disease status between the ages
of 14 and 21 years (N = 61,119).
https://doi.org/10.1371/journal.pone.0193729.g001
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person-years (95%CI: 13.7–32.1) and 1.9 (1.5–2.5), respectively. The ten-fold higher mortality
rate in adolescents with a LTD was expected given the severity of their diseases. However, it
was still very low, even for complex chronic conditions (30.9/10000 person-years; 95%CI;
Fig 2. Evolution of the incidence of hospitalization in short-stay units between 14 and 21 years of age (N = 61,119).
https://doi.org/10.1371/journal.pone.0193729.g002
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17.9–53.2). This low mortality rate in adolescents with a LTD may reflect progress in patient
medical management, but also the fact that the most severe cases possibly died before the age
of 14.
The higher mortality rate of males than females without a LTD is well known and was
expected [24]. Mortality in young males in the general population is mostly related to external
causes (e.g., trauma), supported by more frequent hospitalizations of males than females
among those with no LTD for such causes in our study. This higher risk of external health
issues for males reflects a behavioral gender difference in which more adolescent males partake
in risky behaviors than females in the general population. Surprisingly, we did not observe
such an important gender-gap among youths with a LTD and there was a significant interac-
tion between gender and LTD for both mortality and hospitalization for an external cause. It is
possible that adolescent males with a LTD are less exposed to high-risk behaviors related to
serious injuries requiring hospitalizations than adolescent males of the general population
because of limitations due to their disease. Further research would be needed to address this
hypothesis. In addition, we cannot exclude that this result could be explained by a different
distribution of more severe diseases between males and females, because detailed analysis by
disease was not feasible due to the insufficient number of cases. Similarly, females might have
more severe forms of the diseases, either because males with such severe forms died earlier,
before 14 years, or because females might be registered for their LTD later. In the coming
years, the EGB will include the cause of death, which should allow further investigation of
mortality in males and females with a LTD. Stratification by gender is thus needed for any sub-
sequent study on this topic.
Unsurprisingly, the probability of being hospitalized in a short-stay unit between the ages
of 14 and 21 was higher for youths with a LTD than those without (61.8% vs. 42.7%). It was
not very different or even higher for youths with a non-complex chronic condition than in
those with a complex chronic condition, suggesting that non-complex chronic conditions may
be very demanding and complex to manage on a daily basis. The classification used here,
mainly based on single versus multi-organ diseases, has the advantage of indirectly grouping
diseases for which the management is less well-known by specialists of adults, because they are
historically pediatric multi-organ and/or rare diseases, whereas medical specialties in adult
care are mostly organ-specific. Consequently, it also reflects the difficulty of pediatricians to
find specialists in adult care to transfer a young adult patient. Data based on the International
Classification of Functioning, Disability, and Health would be more relevant for categorizing
patients according to the degree of complexity of their management, but data on activities and
daily functioning are not available in the EGB.
We only included short-stay unit hospitalizations, corresponding to non-psychiatric acute
health events, and hospitalizations for annual check-up for those with a chronic condition.
Long-term stay units are mostly dedicated to rehabilitation and are often preceded by hospital-
ization in a short-stay unit (e.g., for a surgical intervention). Home-hospitalization concerns
mostly dependent elderly patients. Hospitalizations in psychiatric units are not reported here,
which may have led to slight underreporting of overall hospitalizations for youths with a
chronic mental health condition, not hospitalized in a short-stay unit between the ages of 14
and 21 years. We estimated the one-year probability of overnight hospital stay, i.e., by the age
of 15 years in the no LTD group, and found it to be 3.0% (2.8%-3.1%). This probability was
quite similar than the probability estimated in a US study, which reported that 2% of 12-
17-year-old US teens had experienced at least one overnight hospital stay during the previous
12 months in 2015 [25].
The hospitalization rate was higher in subjects with a LTD than in those without a LTD
between the ages of 14 and 21 years and fell sharply at age 19. A decline in the hospitalization
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rate after 18 years of age among LTD adolescents has already been reported in a Canadian
study [15]. However, the decrease for subjects over 18 years of age did not concern hospitaliza-
tions through EDs in our study and neither intensive care unit admissions or ED visits in the
Canadian study. There may be several reasons for these results. First, healthcare needs may
decrease with age for specific diseases, such as asthma, epilepsy, or cured cancers, but this is
probably insufficient to explain the sudden fall at 19 years. Second, planned contacts with the
healthcare system may decrease with changes in living conditions, as 18 is the age of legal
adulthood and the end of secondary school in France. The lack of a decrease in unplanned
acute care may reflect delayed regular care. According to the 2007 survey of Adult Transition
and Health, adolescents (14–17 years) with special healthcare needs received significantly less
timely healthcare as they aged into adulthood (19–23 years) [16]. Third, changes may be
related to transfer to adult-oriented care, potentially associated with a lower frequency of med-
ical visits [26,27], gaps in care [28], a lack of compliance with treatment regimens [29,30], or
different practices between pediatricians and adult specialists (inpatient versus outpatient care,
respectively). Scientific data on this topic are inconsistent [31–33]. We could not explore this
issue, as data on the specialty of the department of hospitalization was not available in the
French national health insurance database during the study period. However, access to care
could be studied in a future analysis by considering data on outpatient care and consultations
with private physicians, which are available in the EGB. This could help to determine whether
there is a discontinuity in patient care or a transition from inpatient care to outpatient care
when the patients become young adults.
Conclusions
This study provides reference epidemiological data on youths living with a LTD in a country
that aims to offer free and universal access to healthcare [34]. Approximately 3% of 14-year-
old youths had a LTD. Elevated risks have been evaluated in detail for the first time in this pop-
ulation, in terms of mortality patterns and trends in hospitalization rates. Unexpectedly, the
rate of planned hospitalization fell after age 18, the age of legal adulthood. This raises many
issues, including coping strategies of young patients in high-risk situations and the role of
transfer to adult care on patient behavior, prognosis, and clinical practices.
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CORRECTION
Correction: Excess mortality and
hospitalizations in transitional-age youths
with a long-term disease: A national
population-based cohort study
Antoine Rachas, Philippe Tuppin, Laurence Meyer, Bruno Falissard, Albert Faye,
Nizar Mahlaoui, Elise de La Rochebrochard, Marie Frank, Pierre Durieux,
Josiane Warszawski
In Fig 2, the labels for “Unplanned hospitalizations” and “Planned hospitalizations” are
switched. Please see the correct Fig 2 here.
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